All In Biotech

Drug Trial Radar · NCT07478822

A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity

An Open-label, Multicenter Clinical Study on The Long-term Safety and Efficacy of Multiple Treatments With Recombinant Botulinum Toxin Type A (YY001) for Injection in Adult Upper Limb Spasticity (REHAB-2)

Last checked: Nov 19, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Mar 27, 2026

Primary completion

Jun 1, 2027

Study completion Jun 1, 2027

Sponsor

Sponsor type
Industry
First posted
Mar 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, multicenter, phase III clinical study to evaluate the long-term safety and efficacy of multiple treatments with recombinant botulinum toxin type A (YY001) for injection in adult upper limb spasticity

Conditions

  • Upper Limb Spasticity

Interventions

  • Recombinant botulinum toxin type A for injection (YY001)Biological

    Prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl), intramuscular injection, the total injection dose for single treatment is 200 to 400 U.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Adverse Events and Serious Adverse EventsTime frame: Up to 48 weeks

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Peking Union Medical College Hospital

    Beijing, China · Recruiting

  • West China Hospital,Sichuan University

    Chengdu, China · Recruiting

  • Guangdong Provincial People's Hospital

    Guangdong, China · Recruiting

  • Sun Yat-sen Memorial Hospital

    Guangzhou, China · Recruiting

  • The Second People's Hospital of Hefei

    Hefei, China · Recruiting

  • Huai'an First Hospital Affiliated to Nanjing Medical University

    Huai'an, China · Recruiting

  • The First Affiliated Hospital of Henan University

    Kaifeng, China · Recruiting

  • The Second Affiliated Hospital of Kunming Medical University

    Kunming, China · Recruiting

  • Shanghai Fudan University HuaShan Hospital

    Shanghai, China · Recruiting

  • Yangzhi Affiliated Rehabilitation Hospital of Tongji University

    Shanghai, China · Recruiting

  • Shenzhen Second People's Hospital

    Shenzhen, China · Recruiting

  • The First Affiliated Hospital of Soochow University

    Suzhou, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, China · Recruiting

  • Xuzhou Medical University Affiliated Hospital

    Xuzhou, China · Recruiting

  • Zibo Municipal Hospital

    Zibo, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.